Ofatumumab monotherapy in relapsed/refractory mantle cell lymphoma--a phase II trial

Br J Haematol. 2014 May;165(4):575-8. doi: 10.1111/bjh.12769. Epub 2014 Feb 8.
No abstract available

Keywords: CD20 antibody; mantle cell lymphoma; ofatumumab.

Publication types

  • Clinical Trial, Phase II
  • Letter

MeSH terms

  • Aged
  • Antibodies, Monoclonal / adverse effects
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Antigens, CD20 / immunology
  • Antineoplastic Agents / adverse effects
  • Antineoplastic Agents / therapeutic use*
  • Fatigue / chemically induced
  • Female
  • Humans
  • Lymphoma, Mantle-Cell / drug therapy*
  • Male
  • Middle Aged
  • Recurrence
  • Salvage Therapy*
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antigens, CD20
  • Antineoplastic Agents
  • ofatumumab